Advanced search

  • Ginekologia Polska
  • Online first Placenta accreta spectrum (PAS) — prenatal diagnosis and management. The Polish Society of Gynecologists and Obstetricians Guidelines
Online first
Guidelines / Expert consensus
Published online: 2024-10-31

open access

View PDF Download PDF file
Page views 759
Article views/downloads 548
Get Citation

Connect on Social Media

Connect on Social Media

Placenta accreta spectrum (PAS) — prenatal diagnosis and management. The Polish Society of Gynecologists and Obstetricians Guidelines

Hubert Huras1, Wojciech Cnota2, Krzysztof Czajkowski3, Mariusz Grzesiak45, Andrzej Jaworowski1, Piotr Kaczmarek6, Sebastian Kwiatkowski7, Bozena Leszczynska-Gorzelak8, Ewa Wender-Ozegowska9, Miroslaw Wielgos1011, Dariusz Wydra12, Mariusz Zimmer13, Piotr Sieroszewski14
DOI: 10.5603/gpl.101422
Pubmed: 39513238

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. Int J Womens Health. 2020; 12: 1033–1045.
    CrossRefPubMed
  2. Bartels HC, Postle JD, Downey P, et al. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers. 2018; 2018: 1507674.
    CrossRefPubMed
  3. Jauniaux E, Chantraine F, Silver RM, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018; 140(3): 265–273.
    CrossRefPubMed
  4. Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019; 221(3): 208–218.
    CrossRefPubMed
  5. Beigi R, Phillips Heine ; R, Silver RM, Wax JR (2012) Number 7 (Replaces Committee Opinion No. 529 {niepełna referencja?} 2012.
  6. Morlando M, Schwickert A, Stefanovic V, et al. International Society for Placenta Accreta Spectrum (IS-PAS). Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study. Acta Obstet Gynecol Scand. 2021; 100 Suppl 1: 41–49.
    CrossRefPubMed
  7. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018; 132(6): e259–e275.
    CrossRefPubMed
  8. Eller AG, Porter TF, Soisson P, et al. Optimal management strategies for placenta accreta. BJOG. 2009; 116(5): 648–654.
    CrossRefPubMed
  9. Bartels HC, Terlizzi K, Cooney N, et al. Quality of life and sexual function after a pregnancy complicated by placenta accreta spectrum. Aust N Z J Obstet Gynaecol. 2021; 61(5): 708–714.
    CrossRefPubMed
  10. Grover B, Einerson BD, Keenan KD, et al. Patient-Reported Health Outcomes and Quality of Life after Peripartum Hysterectomy for Placenta Accreta Spectrum. Am J Perinatol. 2022; 39(3): 281–287.
    CrossRefPubMed
  11. Tol ID, Yousif M, Collins SL. Post traumatic stress disorder (PTSD): The psychological sequelae of abnormally invasive placenta (AIP). Placenta. 2019; 81: 42–45.
    CrossRefPubMed
  12. Collins SL, Alemdar B, van Beekhuizen HJ, et al. International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019; 220(6): 511–526.
    CrossRefPubMed
  13. Einerson BD, Gilner JB, Zuckerwise LC. Placenta Accreta Spectrum. Obstet Gynecol. 2023; 142(1): 31–50.
    CrossRefPubMed
  14. Cnota W, Banas E, Dziechcinska-Poletek D, et al. "The Killer Placenta" - a threat to the lives of young women giving birth by cesarean section. Ginekol Pol. 2022; 93(4): 314–320.
    CrossRefPubMed
  15. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005; 192(5): 1458–1461.
    CrossRefPubMed
  16. Mogos MF, Salemi JL, Ashley M, et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med. 2016; 29(7): 1077–1082.
    CrossRefPubMed
  17. Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966; 95(5): 660–668.
    CrossRefPubMed
  18. Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008; 29(7): 639–645.
    CrossRefPubMed
  19. Jauniaux E, Hussein AM, Elbarmelgy RM, et al. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface. Am J Obstet Gynecol. 2022; 226(2): 243.e1–243.e10.
    CrossRefPubMed
  20. Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012; 33(4): 244–251.
    CrossRefPubMed
  21. Silver RM, Landon MB, Rouse DJ, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006; 107(6): 1226–1232.
    CrossRefPubMed
  22. Timor-Tritsch IE, Monteagudo A, Cali G, et al. Cesarean scar pregnancy and early placenta accreta share common histology. Ultrasound Obstet Gynecol. 2014; 43(4): 383–395.
    CrossRefPubMed
  23. Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016; 123(8): 1348–1355.
    CrossRefPubMed
  24. Jauniaux E, Ayres-de-Campos D. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet. 2018; 140(3): 261–264.
    CrossRefPubMed
  25. Badr DA, Al Hassan J, Salem Wehbe G, et al. Uterine body placenta accreta spectrum: A detailed literature review. Placenta. 2020; 95: 44–52.
    CrossRefPubMed
  26. Miller HE, Leonard SA, Fox KA, et al. Placenta Accreta Spectrum Among Women With Twin Gestations. Obstet Gynecol. 2021; 137(1): 132–138.
    CrossRefPubMed
  27. Modest AM, Toth TL, Johnson KM, et al. Placenta Accreta Spectrum: In Vitro Fertilization and Non-In Vitro Fertilization and Placenta Accreta Spectrum in a Massachusetts Cohort. Am J Perinatol. 2021; 38(14): 1533–1539.
    CrossRefPubMed
  28. Türker Aras ÜA, Korkmazer E, Üstünyurt E. The nightmare of obstetricians - the placenta accreta spectrum in primiparous pregnant women. Ginekol Pol. 2023; 94(2): 135–140.
    CrossRefPubMed
  29. Jauniaux E, Alfirevic Z, Bhide AG, et al. Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019; 126(1): e1–e48.
    CrossRefPubMed
  30. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218(1): 75–87.
    CrossRefPubMed
  31. Jauniaux E, Hecht JL, Elbarmelgy RA, et al. Searching for placenta percreta: a prospective cohort and systematic review of case reports. Am J Obstet Gynecol. 2022; 226(6): 837.e1–837.e13.
    CrossRefPubMed
  32. Einerson B, Comstock J, Silver R, et al. Placenta Accreta Spectrum Disorder. Obstetrics & Gynecology. 2020; 135(5): 1104–1111.
    CrossRef
  33. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019; 146(1): 20–24.
    CrossRefPubMed
  34. Hecht JL, Baergen R, Ernst LM, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020; 33(12): 2382–2396.
    CrossRefPubMed
  35. Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015; 212(5): 561–568.
    CrossRefPubMed
  36. Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011; 117(2 Pt 1): 331–337.
    CrossRefPubMed
  37. Afshar Y, Dong J, Zhao P, et al. Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders. Nat Commun. 2021; 12(1): 4408.
    CrossRefPubMed
  38. Shainker SA, Silver RM, Modest AM, et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020; 223(3): 433.e1–433.e14.
    CrossRefPubMed
  39. Conturie CL, Lyell DJ. Prenatal diagnosis of placenta accreta spectrum. Curr Opin Obstet Gynecol. 2022; 34(2): 90–99.
    CrossRefPubMed
  40. Timor-Tritsch IE, Monteagudo A. Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review. Am J Obstet Gynecol. 2012; 207(1): 14–29.
    CrossRefPubMed
  41. Zimmer M, Sieroszewski P, Wielgoś M, et al. Algorytm postępowania w przypadkach łożyska przodującego i/lub łożyska z nieprawidłową implantacją (PAS). Polskie Towarzystwo Ginekologów i Położników — 2022, cz. I i II. Ginekologia i Perinatologia Praktyczna. 2022; 7: 92–95.
  42. Miller R, Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM), Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #63: Cesarean scar ectopic pregnancy. Am J Obstet Gynecol. 2022; 227(3): B9–BB20.
    CrossRefPubMed
  43. Collins SL, Ashcroft A, Braun T, et al. European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016; 47(3): 271–275.
    CrossRefPubMed
  44. Jauniaux E, Bhide A, Kennedy A, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018; 140(3): 274–280.
    CrossRefPubMed
  45. Hessami K, Salmanian B, Einerson BD, et al. Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022; 140(4): 599–606.
    CrossRefPubMed
  46. Jauniaux E, D'Antonio F, Bhide A, et al. Delphi consensus expert panel. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol. 2023; 61(4): 518–525.
    CrossRefPubMed
  47. Sargent W, Gerry S, Collins SL. A Risk-Prediction Model for Placenta Accreta Spectrum Severity From Standardized Ultrasound Markers. Ultrasound Med Biol. 2023; 49(2): 512–519.
    CrossRefPubMed
  48. Happe SK, Yule CS, Spong CY, et al. Predicting Placenta Accreta Spectrum: Validation of the Placenta Accreta Index. J Ultrasound Med. 2021; 40(8): 1523–1532.
    CrossRefPubMed
  49. Kolak M, Gerry S, Huras H, et al. IS‐PAS group. External validation of and improvement upon a model for the prediction of placenta accreta spectrum severity using prospectively collected multicenter ultrasound data. Acta Obstet Gynecol Scand. 2024 [Epub ahead of print].
    CrossRefPubMed
  50. De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, et al. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022; 59(4): 428–436.
    CrossRefPubMed
  51. Familiari A, Liberati M, Lim P, et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018; 97(5): 507–520.
    CrossRefPubMed
  52. Jha P, Pōder L, Bourgioti C, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol. 2020; 30(5): 2604–2615.
    CrossRefPubMed
  53. Morel O, Collins SL, Uzan-Augui J, et al. International Society for Abnormally Invasive Placenta (IS-AIP). A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) - From the International Society for AIP. Diagn Interv Imaging. 2019; 100(6): 319–325.
    CrossRefPubMed
  54. Einerson BD, Rodriguez CE, Silver RM, et al. Accuracy and Interobserver Reliability of Magnetic Resonance Imaging for Placenta Accreta Spectrum Disorders. Am J Perinatol. 2021; 38(9): 960–967.
    CrossRefPubMed
  55. Bailit JL, Grobman WA, Rice MM, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015; 125(3): 683–689.
    CrossRefPubMed
  56. Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012; 7(12): e52893.
    CrossRefPubMed
  57. Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015; 212(5): 561–568.
    CrossRefPubMed
  58. Levels of Maternal Care: Obstetric Care Consensus No, 9. Obstet Gynecol. 2019; 134(2): e41–e55.
    CrossRefPubMed
  59. Einerson BD, Healy AJ, Lee A, et al. Society for Maternal-Fetal Medicine (SMFM), SMFM Patient Safety and Quality Committee. Electronic address: smfm@smfm.org. Society for Maternal-Fetal Medicine Special Statement: Emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum. Am J Obstet Gynecol. 2024; 230(1): B2–BB11.
    CrossRefPubMed
  60. Sieroszewski P, Bomba-Opon D, Cnota W, et al. Guidelines of the Polish Society of Gynecologists and Obstetricians on the diagnosis and treatment of iron deficiency and iron deficiency with anemia. Ginekol Pol. 2023; 94(5): 415–422.
    CrossRefPubMed
  61. James AH. Iron Deficiency Anemia in Pregnancy. Obstet Gynecol. 2021; 138(4): 663–674.
    CrossRefPubMed
  62. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010; 116(4): 835–842.
    CrossRefPubMed
  63. Allen L, Jauniaux E, Hobson S, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018; 140(3): 281–290.
    CrossRefPubMed
  64. Mhuircheartaigh NR, C DJ (2022) The National Women and Infants Health Programme (NWIHP) and the Institute of Obstetricians and Gynaecologists (IOG) Clinical Advisory Group (CAG) 2022 {niepełna referencja?}.
  65. Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015; 212(2): 218.e1–218.e9.
    CrossRefPubMed
  66. Butwick A, Lyell D, Goodnough L. How do I manage severe postpartum hemorrhage? Transfusion. 2020; 60(5): 897–907.
    CrossRefPubMed
  67. Warrick CM, Rollins MD. Peripartum Anesthesia Considerations for Placenta Accreta. Clin Obstet Gynecol. 2018; 61(4): 808–827.
    CrossRefPubMed
  68. Warrick CM, Sutton CD, Farber MM, et al. Anesthesia Considerations for Placenta Accreta Spectrum. Am J Perinatol. 2023; 40(9): 980–987.
    CrossRefPubMed
  69. Viana Pinto P, Kawka-Paciorkowska K, Morlando M, et al. IS‐PAS group. Prevalence of fetal anomalies, stillbirth, neonatal morbidity, or mortality in pregnancies complicated by placenta accreta spectrum disorders. Acta Obstet Gynecol Scand. 2024 [Epub ahead of print].
    CrossRefPubMed
  70. Bartels HC, Walsh D, Nieto-Calvache AJ, et al. Anesthesia and postpartum pain management for placenta accreta spectrum: The healthcare provider perspective. Int J Gynaecol Obstet. 2024; 164(3): 964–970.
    CrossRefPubMed
  71. Markley JC, Farber MK, Perlman NC, et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. Anesth Analg. 2018; 127(4): 930–938.
    CrossRefPubMed
  72. Clark A, Farber M, Sviggum H, et al. Cesarean Delivery in the Hybrid Operating Suite. Anesthesia & Analgesia. 2013; 117(5): 1187–1189.
    CrossRef
  73. Einerson BD, Weiniger CF. Placenta accreta spectrum disorder: updates on anesthetic and surgical management strategies. Int J Obstet Anesth. 2021; 46: 102975.
    CrossRefPubMed
  74. Çetin F, Sucu S, Özcan HÇ, et al. The potential role of preoperative cystoscopy for determining the depth of invasion in the placenta accreta spectrum. Ginekol Pol. 2023 [Epub ahead of print].
    CrossRefPubMed
  75. Scaglione M, Allshouse A, Canfield D, et al. Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics & Gynecology. 2022; 140(5): 806–811.
    CrossRef
  76. Tam Tam KB, Dozier J, Martin JN. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med. 2012; 25(4): 329–334.
    CrossRefPubMed
  77. Miller HE, Leonard SA, Fox KA, et al. Placenta Accreta Spectrum Among Women With Twin Gestations. Obstet Gynecol. 2021; 137(1): 132–138.
    CrossRefPubMed
  78. Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta. 1987; 8(4): 399–409.
    CrossRefPubMed
  79. Teixidor Viñas M, Chandraharan E, Moneta MV, et al. The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta. Clin Radiol. 2014; 69(8): e345–e351.
    CrossRefPubMed
  80. Takahashi H, Ohkuchi A, Usui R, et al. Factors Contributing to Massive Blood Loss on Peripartum Hysterectomy for Abnormally Invasive Placenta: Who Bleeds More? Obstet Gynecol Int. 2016; 2016: 5349063.
    CrossRefPubMed
  81. Luo F, Xie L, Xie P, et al. Intraoperative aortic balloon occlusion in patients with placenta previa and/or placenta accreta: a retrospective study. Taiwan J Obstet Gynecol. 2017; 56(2): 147–152.
    CrossRefPubMed
  82. Chou MM, Kung HF, Hwang JI, et al. Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation. Taiwan J Obstet Gynecol. 2015; 54(5): 493–498.
    CrossRefPubMed
  83. Pyra K, Szmygin M, Dymara-Konopka W, et al. Maternal and perinatal outcomes in placenta accreta spectrum disorders with prophylactic internal iliac artery balloon catheterization and embolization. Ginekol Pol. 2022; 93(12): 980–986.
    CrossRefPubMed
  84. Clausen C, Stensballe J, Albrechtsen CK, et al. Balloon occlusion of the internal iliac arteries in the multidisciplinary management of placenta percreta. Acta Obstet Gynecol Scand. 2013; 92(4): 386–391.
    CrossRefPubMed
  85. Bodner LJ, Nosher JL, Gribbin C, et al. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 2006; 29(3): 354–361.
    CrossRefPubMed
  86. Salim R, Chulski A, Romano S, et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. Obstet Gynecol. 2015; 126(5): 1022–1028.
    CrossRefPubMed
  87. Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013; 92(10): 1125–1134.
    CrossRefPubMed
  88. Matsueda S, Hidaka N, Kondo Y, et al. External iliac artery thrombosis after common iliac artery balloon occlusion during cesarean hysterectomy for placenta accreta in cervico-isthmic pregnancy. J Obstet Gynaecol Res. 2015; 41(11): 1826–1830.
    CrossRefPubMed
  89. Bishop S, Butler K, Monaghan S, et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 2011; 20(1): 70–73.
    CrossRefPubMed
  90. Gagnon J, Boucher L, Kaufman I, et al. Iliac artery rupture related to balloon insertion for placenta accreta causing maternal hemorrhage and neonatal compromise. Can J Anaesth. 2013; 60(12): 1212–1217.
    CrossRefPubMed
  91. Teare J, Evans E, Belli A, et al. Sciatic nerve ischaemia after iliac artery occlusion balloon catheter placement for placenta percreta. Int J Obstet Anesth. 2014; 23(2): 178–181.
    CrossRefPubMed
  92. Greenberg JI, Suliman A, Iranpour P, et al. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case. Am J Obstet Gynecol. 2007; 197(5): 470.e1–470.e4.
    CrossRefPubMed
  93. Sentilhes L, Kayem G, Chandraharan E, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018; 140(3): 291–298.
    CrossRefPubMed
  94. Paping A, Bluth A, Al Naimi A, et al. IS‐PAS. Opportunities for, and barriers to, uterus-preserving surgical techniques for placenta accreta spectrum. Acta Obstet Gynecol Scand. 2024 [Epub ahead of print].
    CrossRefPubMed
  95. Kwiatkowski S, Huras H, Fuchs T, et al. Rekomendacje Polskiego Towarzystwa Ginekologów i Położników. Postępowania w przypadku wystąpienia krwotoków okołoporodowych. Ginekologia i Perinatologia Praktyczna. 2022; 7: 34–45.
  96. Jolley JA, Nageotte MP, Wing DA, et al. Management of placenta accreta: a survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med. 2012; 25(6): 756–760.
    CrossRefPubMed
  97. Esakoff TF, Handler SJ, Granados JM, et al. PAMUS: placenta accreta management across the United States. J Matern Fetal Neonatal Med. 2012; 25(6): 761–765.
    CrossRefPubMed
  98. Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 217(1): 27–36.
    CrossRefPubMed
  99. Buyukkurt S, Sucu M, Hatipoglu I, et al. Placenta accreta spectrum surgery with the Joel Cohen incision for abdominal access: a single-center experience. Ginekol Pol. 2023 [Epub ahead of print].
    CrossRefPubMed
  100. Wright JD, Herzog TJ, Shah M, et al. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol. 2010; 115(6): 1194–1200.
    CrossRefPubMed
  101. Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010; 115(3): 526–534.
    CrossRefPubMed
  102. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007; 62(8): 529–539.
    CrossRefPubMed
  103. Bręborowicz GH, Markwitz W, Gaca M, et al. Conservative management of placenta previa complicated by abnormal placentation. J Matern Fetal Neonatal Med. 2013; 26(10): 1012–1015.
    CrossRefPubMed
  104. Pather S, Strockyj S, Richards A, et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol. 2014; 54(1): 84–87.
    CrossRefPubMed
  105. Clausen C, Lönn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014; 93(2): 138–143.
    CrossRefPubMed
  106. Miyakoshi K, Otani T, Kondoh E, et al. Perinatal Research Network Group in Japan. Retrospective multicenter study of leaving the placenta in situ for patients with placenta previa on a cesarean scar. Int J Gynaecol Obstet. 2018; 140(3): 345–351.
    CrossRefPubMed
  107. Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013; 92(10): 1125–1134.
    CrossRefPubMed
  108. Zuckerwise LC, Craig AM, Newton JM, et al. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020; 222(2): 179.e1–179.e9.
    CrossRefPubMed
  109. Gatta LA, Weber JM, Gilner JB, et al. Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy. Am J Perinatol. 2022; 29(14): 1503–1513.
    CrossRefPubMed
  110. Chandraharan E, Rao S, Belli AM, et al. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012; 117(2): 191–194.
    CrossRefPubMed
  111. Aryananda RA, Aditiawarman A, Gumilar KE, et al. Uterine conservative-resective surgery for selected placenta accreta spectrum cases: Surgical-vascular control methods. Acta Obstet Gynecol Scand. 2022; 101(6): 639–648.
    CrossRefPubMed
  112. Palacios-Jaraquemada JM, Fiorillo A, Hamer J, et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2022; 35(2): 275–282.
    CrossRefPubMed
  113. Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aryananda R, et al. How to perform the one-step conservative surgery for placenta accreta spectrum move by move. Am J Obstet Gynecol MFM. 2023; 5(2): 100802.
    CrossRefPubMed
  114. Clausen C, Lönn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014; 93(2): 138–143.
    CrossRefPubMed
  115. Abo-Elroose AAE, Ahmed MR, Shaaban MM, et al. Triple P with T-shaped lower segment suture; an effective novel alternative to hysterectomy in morbidly adherent anterior placenta previa. J Matern Fetal Neonatal Med. 2021; 34(19): 3187–3191.
    CrossRefPubMed
  116. Dawood AS, Elgergawy AE, Elhalwagy AE. Evaluation of three-step procedure (Shehata's technique) as a conservative management for placenta accreta at a tertiary care hospital in Egypt. J Gynecol Obstet Hum Reprod. 2019; 48(3): 201–205.
    CrossRefPubMed
  117. Palacios-Jaraquemada JM, Basanta N, Labrousse C, et al. Pregnancy outcome in women with prior placenta accreta spectrum disorders treated with conservative-reconstructive surgery: analysis of 202 cases. J Matern Fetal Neonatal Med. 2022; 35(25): 6297–6301.
    CrossRefPubMed
  118. Provansal M, Courbiere B, Agostini A, et al. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynaecol Obstet. 2010; 109(2): 147–150.
    CrossRefPubMed
  119. Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010; 25(11): 2803–2810.
    CrossRefPubMed
  120. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013; 17(2): R76.
    CrossRefPubMed
  121. Pacagnella RC, Borovac-Pinheiro A. Assessing and managing hypovolemic shock in puerperal women. Best Pract Res Clin Obstet Gynaecol. 2019; 61: 89–105.
    CrossRefPubMed
  122. Nolan JP, Pullinger R. Hypovolaemic shock. BMJ. 2014; 348: g1139.
    CrossRefPubMed
  123. Silva J, Gonçalves L, Sousa PP. Fluid therapy and shock: an integrative literature review. Br J Nurs. 2018; 27(8): 449–454.
    CrossRefPubMed
  124. McNamara H, Mallaiah S, Barclay P, et al. Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. Int J Obstet Anesth. 2015; 24(2): 174–179.
    CrossRefPubMed
  125. Grottke O, Frietsch T, Maas M, et al. German Society of Anaesthesiology and Intensive Care Medicine. [Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine]. Anaesthesist. 2013; 62(3): 213–16, 218.
    CrossRefPubMed
  126. James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009; 201(1): 12.e1–12.e8.
    CrossRefPubMed
  127. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389(10084): 2105–2116.
    CrossRefPubMed
  128. Lavigne-Lissalde G, Aya AG, Mercier FJ, et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost. 2015; 13(4): 520–529.
    CrossRefPubMed
  129. Segal S, Shemesh IY, Blumental R, et al. The use of recombinant factor VIIa in severe postpartum hemorrhage. Acta Obstet Gynecol Scand. 2004; 83(8): 771–772.
    CrossRefPubMed
  130. Yang JI, Lim YK, Kim HS, et al. Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior Cesarean section. Ultrasound Obstet Gynecol. 2006; 28(2): 178–182.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note